Inflammation has been suggested as a potential pathway by which insomnia and short sleep can affect risk of morbidity in adults. However, few studies have examined the association of insomnia with inflammation in adolescents, despite accumulating evidence that pathophysiologic changes may already occur during this critical developmental period. The present study sought to examine the association of insomnia symptoms with systemic inflammation and the role of objective sleep duration in this association. Participants were 378 adolescents (16.9 ± 2.3 y, 45.8% female) from the Penn State Child Cohort, a population-based sample who underwent 9-h polysomnography (PSG) followed by a single fasting blood draw to assess plasma levels of C-reactive protein (CRP) and other inflammatory markers. Insomnia symptoms were defined by a self-report of difficulties falling and/or staying asleep, while objective sleep duration groups were defined as a PSG total sleep time P8, 8-7, and 67 h. We assessed the association of insomnia symptoms, objective sleep duration, and their interaction with inflammatory markers, while adjusting for multiple potential confounders. Adolescents reporting insomnia symptoms had significantly higher levels of CRP compared to controls and a significant interaction (p < 0.01) showed that objective sleep duration modified this association. Elevated CRP was present in adolescents with insomnia symptoms and 67 h of sleep (1.79 mg/L) as compared to controls or adolescents with insomnia symptoms and P8 h of sleep (0.90 mg/L and 0.98 mg/L, respectively) or controls with 67 h of sleep (0.74 mg/L; all pvalues <0.01). In sum, insomnia symptoms with objective short sleep duration are associated with systemic inflammation as early as adolescence. This study suggests that chronic low-grade inflammation may be a common final pathway towards morbidity in adulthood in this insomnia phenotype.
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Introduction
Insomnia, particularly in adults with objective short sleep duration, has been associated with increased physiologic indices of hyperarousal, ranging from increased cortisol and norepinephrine levels, whole-body metabolic rate and impaired heart rate variability to increased high-frequency cortical dynamics, cerebral glucose metabolism and decreased gamma-aminobutyric acid levels (Bonnet and Arand, 2010; Riemann et al., 2010; Vgontzas et al., 2013) . Furthermore, adults with insomnia and objective short sleep duration have been found to be at increased risk of hypertension, type 2 diabetes, neurocognitive impairment, depression and mortality (Bathgate et al., 2016; Fernandez-Mendoza et al., 2015; Vgontzas et al., 2013) . Thus, there is a need to identify biomarkers to target the diagnosis and treatment of these adverse health outcomes early in the life span. Chronic low-grade inflammation has been proposed as one of the potential paths by which insomnia can lead to adverse health outcomes (Irwin, 2015; Vgontzas et al., 2002 Vgontzas et al., , 2013 . However, little is known about the association of adolescent insomnia with inflammation, despite accumulating evidence that the main pathophysiologic mechanism of insomnia, i.e., hyperarousal, may already be present during this critical developmental period (Fernandez-Mendoza et al., 2014 , 2016 Ly et al., 2015; Zhang et al., 2014) . This period is also when sleep disorders develop and, therefore, marks a point for potential interventions; indeed, the prevalence of insomnia symptoms increases with the onset of puberty (Calhoun et al., 2014) , reaching a peak of 40% in adolescence, similar to the prevalence of insomnia symptoms in adults (Ohayon, 2002 
